MAPT and Alzheimer disease: According to research findings, cerebrospinal fluid β-amyloid and tau proteins are typical fluid biomarkers of the AD continuum (Lantero-Rodriguez et al., 2024), but their detection methods suffer from high invasiveness and costliness.